ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 015,97
0,24%
Dow Jones
38 852,27
0,46%
DAX
18 248,75
0,42%
Brent Oil
83,47
-0,01%
Bitcoin
64 122,12
1,51%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) Actualités

PSNL Personalis Inc

1,59
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Personalis Inc PSNL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,59 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,59
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202422:01BWPersonalis to Announce First Quarter 2024 Financial Results
28/3/202421:01BWPersonalis to Present at the 23rd Annual Needham Virtual..
28/3/202414:00BWData Showcasing NeXT Personal MRD Test to be Presented at..
26/3/202414:00BWPersonalis Announces Publication Validating NeXT Personal®..
19/3/202421:43BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
28/2/202422:01BWPersonalis Reports Fourth Quarter and Full Year 2023..
28/2/202422:00EDGAR2Form 8-K - Current report
14/2/202422:01BWPersonalis to Announce Fourth Quarter and Full Year 2023..
31/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:01BWPersonalis to Participate at Upcoming Investor Conferences
30/1/202415:00BWPersonalis and ClearNote Health Announce Partnership to..
29/1/202422:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202422:15BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
16/1/202415:05BWPersonalis Announces Medicare Coverage for NeXT Dx(R)..
10/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
05/1/202415:09EDGAR2Form 8-K - Current report
05/1/202415:05BWPersonalis Reports Preliminary Fourth Quarter and Full Year..
21/12/202323:15EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202323:12EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202300:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/12/202315:15BWPersonalis Extends Cash Position Into 2026, Provides Update..
01/12/202322:51EDGAR2Form 8-K - Current report
28/11/202322:58EDGAR2Form 8-K - Current report
28/11/202322:15BWPersonalis and Tempus Enter into a Strategic Collaboration..
20/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:01BWPersonalis Reports Third Quarter 2023 Financial Results
07/11/202322:00EDGAR2Form 8-K - Current report
26/10/202314:15BWPersonalis Launches NeXT Personal® Dx for Early Access..
24/10/202322:01BWPersonalis to Announce Third Quarter 2023 Financial Results
21/10/202310:25BWAnalysis from TRACERx Study Reveals More Sensitive and..
19/10/202313:15BWPersonalis Announces Late-Breaking NeXT Personal Abstract..
18/10/202313:15BWPersonalis Appoints Former Roche Diagnostics and GRAIL..
29/8/202322:01BWPersonalis to Present at the 21st Annual Morgan Stanley..
28/8/202323:11EDGAR2Form 8-K - Current report
25/8/202301:01BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
08/8/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:01EDGAR2Form 8-K - Current report
08/8/202322:01BWPersonalis Reports Second Quarter 2023 Financial Results
02/8/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202322:01BWPersonalis to Participate at Upcoming Investor Conferences
25/7/202322:01BWPersonalis to Announce Second Quarter 2023 Financial Results
26/6/202323:00BWPersonalis Files Second Patent Infringement Suit Against..
14/6/202301:01BWDr. Kenneth J. Widder Joins Personalis Board of Directors
30/5/202314:00BWPersonalis Announces Two Abstracts Accepted for Presentation..
16/5/202322:19BWPersonalis、国立がん研究センター東病院、小野薬品が提携、直腸がん免疫療法反応の予測向上へ
16/5/202314:00BWPersonalis, National Cancer Center Hospital East, and Ono..

Dernières Valeurs Consultées

NASDAQ
PSNL
Personalis
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés